suboxone
Generic: buprenorphine hydrochloride, naloxone hydrochloride
Labeler: indivior inc.Drug Facts
Product Profile
Brand Name
suboxone
Generic Name
buprenorphine hydrochloride, naloxone hydrochloride
Labeler
indivior inc.
Dosage Form
FILM, SOLUBLE
Routes
Active Ingredients
buprenorphine hydrochloride 4 mg/1, naloxone hydrochloride 1 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
12496-1204
Product ID
12496-1204_ad5a289a-6285-4b2d-b7ad-e4812169dd58
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA022410
DEA Schedule
ciii
Listing Expiration
2027-12-31
Marketing Start
2012-08-24
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
124961204
Hyphenated Format
12496-1204
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
suboxone (source: ndc)
Generic Name
buprenorphine hydrochloride, naloxone hydrochloride (source: ndc)
Application Number
NDA022410 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 4 mg/1
- 1 mg/1
Packaging
- 30 POUCH in 1 CARTON (12496-1204-3) / 1 FILM, SOLUBLE in 1 POUCH (12496-1204-1)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["BUCCAL", "SUBLINGUAL"], "spl_id": "ad5a289a-6285-4b2d-b7ad-e4812169dd58", "openfda": {"upc": ["0312496120835"], "unii": ["56W8MW3EN1", "F850569PQR"], "rxcui": ["1010600", "1010603", "1010604", "1010606", "1307056", "1307058", "1307061", "1307063"], "spl_set_id": ["8a5edcf9-828c-4f97-b671-268ab13a8ecd"], "manufacturer_name": ["INDIVIOR INC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 POUCH in 1 CARTON (12496-1204-3) / 1 FILM, SOLUBLE in 1 POUCH (12496-1204-1)", "package_ndc": "12496-1204-3", "marketing_start_date": "20120824"}], "brand_name": "Suboxone", "product_id": "12496-1204_ad5a289a-6285-4b2d-b7ad-e4812169dd58", "dosage_form": "FILM, SOLUBLE", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]", "Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "12496-1204", "dea_schedule": "CIII", "generic_name": "buprenorphine hydrochloride, naloxone hydrochloride", "labeler_name": "INDIVIOR INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Suboxone", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "4 mg/1"}, {"name": "NALOXONE HYDROCHLORIDE", "strength": "1 mg/1"}], "application_number": "NDA022410", "marketing_category": "NDA", "marketing_start_date": "20120824", "listing_expiration_date": "20271231"}